Compare LTRX & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LTRX | STXS |
|---|---|---|
| Founded | 1989 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Communications Equipment | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 237.4M | 210.0M |
| IPO Year | 2000 | 2004 |
| Metric | LTRX | STXS |
|---|---|---|
| Price | $6.05 | $2.21 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $6.50 | $4.00 |
| AVG Volume (30 Days) | ★ 1.4M | 496.8K |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $122,923,000.00 | $29,346,617.00 |
| Revenue This Year | $1.12 | $24.21 |
| Revenue Next Year | $15.27 | $29.83 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.91 | $1.54 |
| 52 Week High | $8.24 | $3.59 |
| Indicator | LTRX | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 50.49 | 46.88 |
| Support Level | $6.05 | $2.04 |
| Resistance Level | $6.75 | $2.23 |
| Average True Range (ATR) | 0.44 | 0.11 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 61.23 | 86.67 |
Lantronix Inc is a networking company. It provides secure data access and management solutions for the Internet of Things (IoT) and information technology assets. It organizes its products and solutions into three product lines: Embedded IoT Solutions, IoT Systems Solutions, and Software and Services. The IoT System Solutions segment is the key revenue driver for the company. The company serves a diverse range of markets including healthcare, industrial, security, energy, transportation, and government networking. Its primary geographic markets are the Americas, Europe, the Middle East and Africa, and Asia Pacific Japan. The Americas contribute the vast majority of total revenue.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.